Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Carter Bankshares, Inc.NASDAQ: CARE
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows in line with its trailing trend
Q1 FY2026 depreciation & amortization of $2.13M rose 11.6% year over year, ahead of the +10.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 4.3% from the prior quarter. Over 3 fiscal years it compounded at +9.0% a year.
Context
- Depreciation & amortization amounted to 3.1% of revenue in FY2025, up 0.1 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +11.6% holds above the trailing-twelve-month pace of +10.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 7.86M USD
- Year-over-year change
- +11.4%
- 4-year CAGR
- +6.0%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.86M | +11.4% |
| FY2024 | 2024-12-31 | 7.06M | +12.9% |
| FY2023 | 2023-12-31 | 6.25M | +3.1% |
| FY2022 | 2022-12-31 | 6.06M | -2.7% |
| FY2021 | 2021-12-31 | 6.23M | — |
Depreciation & Amortization vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's LTM Mar 2026 depreciation & amortization of $8.08M is the largest of the 11 companies compared; the peer median is $3.73M.
- Its year-over-year change of +10.8% is the 3rd highest of 11, against a peer median of -7.1%.
- Depreciation & amortization amounts to 2.5% of revenue for CARE, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $8.08M | +10.8% | +9.0% | 2.5% | |
| LTM Mar 2026 | $6.09M | +68.9% | -44.2% | 2.5% | |
| LTM Mar 2026 | $5.83M | -9.1% | +0.3% | 3.3% | |
| LTM Mar 2026 | $4.22M | +10.7% | +6.7% | 2.0% | |
| LTM Mar 2026 | $4.16M | -5.0% | +39.4% | 1.7% | |
| LTM Mar 2026 | $3.75M | -21.3% | +8.6% | 1.8% | |
| LTM Mar 2026 | $3.71M | -5.0% | -6.7% | 2.0% | |
| LTM Mar 2026 | $2.73M | -15.8% | -3.9% | 0.4% | |
| LTM Mar 2026 | $2.36M | +85.2% | +52.3% | 2.7% | |
| LTM Mar 2026 | $2.23M | -11.4% | -13.3% | 1.5% | |
| LTM Mar 2026 | $310K | -25.8% | -21.1% | 0.3% | |
| Peer median (excluding CARE) | $3.73M | -7.1% | -1.8% | 1.9% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 31.59M | 50.12M | 23.38M | 24.52M | 31.36M |
| Depreciation & Amortization | 6.23M | 6.06M | 6.25M | 7.06M | 7.86M |
| Deferred Income Tax | 4.82M | 4.25M | 2.47M | 3.21M | 2.82M |
| Stock-Based Compensation | 1.04M | 1.31M | 1.56M | 1.75M | 2.07M |
| Change in Working Capital | 5.61M | (722K) | (1.43M) | 1.83M | (1.98M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 5.61M | (722K) | (1.43M) | 1.83M | (1.98M) |
| Other Non-Cash Items | 28.25M | 9.77M | 14.5M | (1.43M) | (2.27M) |
| Operating Cash Flow | 77.54M | 70.79M | 46.73M | 36.94M | 39.86M |
| Capital Expenditures | (8.48M) | (5.89M) | (9.8M) | (8.13M) | (8.06M) |
| Acquisitions (Net) | (73.92M) | 0 | 0 | 0 | 53.57M |
| Purchases of Investments | (466.65M) | (135.63M) | (24.94M) | (25.13M) | (63.68M) |
| Sales of Investments | 307.25M | 104.47M | 92.22M | 81.41M | 115.93M |
| Other Investing Activities | 135.45M | (345.02M) | (364.5M) | (116.55M) | (253.68M) |
| Investing Cash Flow | (106.36M) | (382.07M) | (307.01M) | (68.4M) | (155.91M) |
| Debt Repayment | (28M) | 173.55M | 194.98M | (323.4M) | 108.5M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (157K) | (42.93M) | (16.42M) | 0 | (20M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 92.83M | (50.27M) | 89.38M | 431.51M | 1.54M |
| Financing Cash Flow | 64.67M | 80.35M | 267.94M | 108.11M | 90.04M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 35.86M | (230.93M) | 7.66M | 76.64M | (26.01M) |
| Free Cash Flow | 69.05M | 64.9M | 36.93M | 28.81M | 31.81M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.